EPIX NASDAQ
ESSA Pharma Inc.
1W: -7.5%
1M: -1.9%
3M: -5.0%
1Y: -73.6%
3Y: -9.2%
5Y: -75.2%
$0.20
Last traded 2025-10-09 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$128M
-14.1% ▼
5Y CAGR: +18.5%
Total Liabilities
$4M
+0.3% ▲
5Y CAGR: -8.9%
Shareholders Equity
$125M
-14.4% ▼
5Y CAGR: +20.4%
Cash & Investments
$127M
-14.4% ▼
5Y CAGR: +18.9%
Total Debt
$329K
+309.9% ▲
5Y CAGR: -38.4%
Net Debt
-$103M
-207.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $56M | $138M | $57M | $34M | $104M |
| Short-Term Investments | $0 | $57M | $0 | $114M | $23M |
| Cash & ST Investments | $56M | $195M | $57M | $148M | $127M |
| Net Receivables | $310K | $489K | $6K | $135K | $163K |
| Inventory | -$310K | $0 | $111M | $0 | $0 |
| Other Current Assets | $180K | $0 | $0 | $379K | $0 |
| Total Current Assets | $81M | $198M | $170M | $149M | $128M |
| Property, Plant & Equip. | $55K | $308K | $186K | $68K | $295K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $259K | $259K | $257K | $257K |
| Total Non-Current Assets | $55K | $568K | $446K | $325K | $552K |
| Total Assets | $81M | $198M | $170M | $149M | $128M |
| — Liabilities — | |||||
| Accounts Payable | $679K | $1M | $955K | $2M | $2M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $124K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $541K | $478K |
| Total Current Liabilities | $1M | $4M | $2M | $3M | $3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $127K | $20K | $183 | $0 | $0 |
| Total Non-Current Liabilities | $127K | $231K | $77K | $0 | $205K |
| Total Liabilities | $1M | $4M | $2M | $3M | $4M |
| — Equity — | |||||
| Common Stock | $131M | $277M | $278M | $278M | $280M |
| Retained Earnings | -$81M | -$118M | -$153M | -$179M | -$208M |
| Accumulated OCI | -$2M | -$2M | -$2M | -$2M | -$2M |
| Total Stockholders Equity | $79M | $194M | $167M | $146M | $125M |
| Total Liabilities & Equity | $81M | $198M | $170M | $149M | $128M |
| — Key Metrics — | |||||
| Total Debt | $59K | $331K | $210K | $80K | $329K |
| Net Debt | -$56M | -$137M | -$57M | -$34M | -$103M |
| Total Investments | $0 | $57M | $0 | $114M | $23M |